Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression

Volume: 275, Pages: 119369 - 119369
Published: Jun 1, 2021
Abstract
Despite extensive efforts to find new treatments, chemotherapy is still one of the first and foremost choices for cancer treatment. The main problems of using these drugs are the resistance of cancer cells and reducing their sensitivity to chemotherapy as well as the side effects of their systemic administration. Because STAT3 plays a very important role in the survival and susceptibility of cancer cells to apoptosis, we hypothesized that...
Paper Details
Title
Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression
Published Date
Jun 1, 2021
Volume
275
Pages
119369 - 119369
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.